← Evidence map

ArticleAntimicrobial agents and chemotherapy2003

Mutant prevention concentration of garenoxacin (BMS-284756) for ciprofloxacin-susceptible or -resistant Staphylococcus aureus.

Xilin Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

14 papers cite it

2003

2004

2005

2006

2007

2008

2009

2010

2011

2012

2013

2014

2015

2016

2017

2018

2019

2020

2021

this papertrialcites it

Mutant prevention concentration of garenoxacin (BMS-284756) for ciprofloxacin-susceptible or -resistant Staphylococcus aureus. | OpenQuestion